Form D · Biotechnology
CalciMedica, Inc.
La Jolla, CA · CIK 0001534133
Offering snapshot reported Apr 4, 2023 · SEC filing
- Reported sold
- $9.11M Offering amount: $9.11M
- Investors reported
- 55 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2023 | Initial | $9,109,912 | No comparison | 55 | SEC filing |
| Aug 15, 2019 | Initial | $54,999,994 | No comparison | 8 | SEC filing |
| Jun 13, 2018 | Amendment | $75,393,829 | $42,450,133vs Jul 18, 2017 | 16 | SEC filing |
| Jul 18, 2017 | Amendment | $32,943,696 | $11,999,997vs May 13, 2016 | 16 | SEC filing |
| May 13, 2016 | Initial | $20,943,699 | No comparison | 15 | SEC filing |
| Dec 21, 2015 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Mar 6, 2015 | Initial | $1,740,000 | No comparison | 2 | SEC filing |
| Oct 7, 2014 | Initial | $750,000 | No comparison | 3 | SEC filing |
| Oct 10, 2013 | Amendment | $1,455,000 | $250,000vs Sep 18, 2013 | 7 | SEC filing |
| Sep 18, 2013 | Initial | $1,205,000 | No comparison | 6 | SEC filing |
| Nov 8, 2011 | Initial | $610,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-477891
Offering of Issuer common stock and warrants to purchase shares of Issuer common stock.
Source: Form D, filed Apr 4, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Bjerkholt | Director |
| Gerald Cagle | Director |
| Gerald Cagle, Ph.D. | Director |
| Jeffrey Cleland | Director, Executive |
| Emmett Cunningham | Director |
| Emmett Cunningham, M.D., Ph.D. | Director |
| Michael J. Dunn | Executive |
| Daniel Geffken | Executive |
| Frederic Guerard | Director |
| Justin Hanes | Director |
| Sudarshan Hebbar | Executive |
| Hansoo Michael Keyoung | Director |
| Chau Khoung | Director |
| Chau Khuong | Director |
| A. Rachel Leheny | Director, Executive |
| Fred Middleton | Director |
| Michael O'rourke | Director, Executive |
| Eric W. Roberts | Director, Executive |
| Christy Shaffer | Director |
| Christy Shaffer, Ph.D. | Director |
| Allan Shaw | Director |
| Kenneth A. Stauderman | Executive |
| Pamela Wapnick | Executive, Promoter |
| Cameron Wheeler | Director |
| Cameron Wheeler, Ph.D. | Director |
| Robert N. Wilson | Director |
| Christy Wyskiel | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
505 Coast Boulevard South Suite 307
La Jolla, CA, 92037
La Jolla, CA, 92037